Avalo Therapeutics (NASDAQ: AVTX) insider to sell shares

Rhea-AI Filing Summary

A person associated with AVTX has filed a notice of intent to sell common stock. The planned sale covers 3,749 shares of AVTX common stock, with an indicated aggregate market value of 74,762.10, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 17, 2026 on the NASDAQ market.

The shares come from multiple sources, including 2,876 shares acquired via an exercise of options under a registered plan on August 17, 2026 and several smaller lots (such as 450 shares and 417 shares) purchased through an Employee Stock Purchase Plan between 2020 and 2025.

Key Figures

Shares to be sold: 3,749 shares Aggregate market value: 74,762.10 Planned sale date: 08/17/2026 +3 more

6 metrics

Shares to be sold 3,749 shares Total AVTX common shares covered by the Form 144 notice

Aggregate market value 74,762.10 Aggregate market value of 3,749 AVTX shares proposed for sale

Planned sale date 08/17/2026 Intended date of AVTX share sale on NASDAQ

Shares from option exercise 2,876 shares AVTX shares acquired by exercise of options under a registered plan on 08/17/2026

ESPP purchase 450 shares AVTX shares purchased through Employee Stock Purchase Plan on 06/10/2026

ESPP purchase 417 shares AVTX shares purchased through Employee Stock Purchase Plan on 12/10/2025

Key Terms

Form 144, Exercise of Options Under a Registered Plan, Employee Stock Purchase Plan, aggregate market value

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Options Under a Registered Plan financial

"Common | 08/17/2026 | Exercise of Options Under a Registered Plan"

Employee Stock Purchase Plan financial

"Shares Purchased Through Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

aggregate market value financial

"3749 | 74762.10 | 53630000 | 08/17/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the AVTX Form 144 filing disclose about planned stock sales?

The Form 144 reports an intent to sell 3,749 shares of AVTX common stock, with an aggregate market value of 74,762.10, through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 17, 2026 on NASDAQ.

How many AVTX shares from option exercises are included in this Form 144?

The filing shows 2,876 shares of AVTX common stock to be sold that were acquired by exercise of options under a registered plan on August 17, 2026, forming the largest single component of the proposed sale.

What AVTX shares from the Employee Stock Purchase Plan are covered by this Form 144?

The notice includes several lots of AVTX shares from an Employee Stock Purchase Plan, including 450 shares acquired on June 10, 2026 and 417 shares acquired on December 10, 2025, plus small lots of 1–2 shares from 2020–2023.

What is the aggregate market value of AVTX shares in this Form 144?

The proposed sale covers AVTX common stock with an aggregate market value of 74,762.10. This value corresponds to the 3,749 shares planned for sale through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

Which broker is handling the AVTX Form 144 proposed share sale?

The proposed sale of 3,749 AVTX shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as indicated in the Form 144 disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:19 PM Accepted by SEC EDGAR 08/17/2026 - 04:18 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3749	74762.10	53630000	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Exercise of Options Under a Registered Plan	Issuer			2876	08/17/2026	Services Rendered
Common	06/10/2026	Shares Purchased Through Employee Stock Purchase Plan	Issuer			450	06/10/2026	Compensation
Common	06/10/2020	Shares Purchased Through Employee Stock Purchase Plan	Issuer			2	06/10/2020	Compensation
Common	12/10/2020	Shares Purchased Through Employee Stock Purchase Plan	Issuer			2	12/10/2020	Compensation
Common	12/10/2021	Shares Purchased Through Employee Stock Purchase Plan	Issuer			1	12/10/2021	Compensation
Common	06/09/2023	Shares Purchased Through Employee Stock Purchase Plan	Issuer			1	06/09/2023	Compensation
Common	12/10/2025	Shares Purchased Through Employee Stock Purchase Plan	Issuer			417	12/10/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)